NCT00023855View on ClinicalTrials.gov

PS-341 and Doxorubicin in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2001

Primary Completion Date

October 31, 2003

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

bortezomib

DRUG

doxorubicin hydrochloride

Trial Locations (1)

53792-6164

University of Wisconsin Comprehensive Cancer Center, Madison

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Wisconsin, Madison

OTHER

NCT00023855 - PS-341 and Doxorubicin in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter